NEW YORK (GenomeWeb News) – Shares of Sequenom climbed 49 percent during the month of November as the firm tries to rebound from a clinical study scandal that led to the dismissal of senior executives at the firm two months ago.

Sequenom led the 34 stocks that comprise the GenomeWeb Daily News Index, while Decode Genetics' shares dropped 88 percent as the firm filed for Chapter 11 bankruptcy protection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.